GLP-1 Agonists - What is it?
US$ 20.15
retatrutide weight loss study results New Phase 3 data just dropped ๐ Eli Lilly's trial reported average approaching 30%, with some patients achieving historically associated with bariatric surgery. A few important caveats Retatrutide Results: How Much Weight
Description
July 10, 2023
Physician-supervised compounded tirzepatide and retatrutide with provider-led dose titration, quarterly check-ins, and an included annual DEXA scan
Low iron causes fatigue and reduced exercise tolerance again, symptoms that overlap with GLP-1 side effects and may go unrecognised as deficiency
Stay tuned to Big Molecule Watch for further developments on this case
Average weight loss before stopping was 4.4%, and one year later, this group had actually lost an additional 1.3%
